Solos Endoscopy, Inc. Outlines Marketing Strategy for 2010 Campaign
BOSTON, Dec. 23 Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has outlined its 2010 marketing strategy as developed by Advertising Associates International based out of Boston, Massachusetts. The marketing campaign will focus primarily on the MammoView(TM) line. The campaign will include the distribution of articles to medical publications, development of a media-advertising program, production of booth displays for industry trade shows, and the development of Solos MammoView(TM) Breast Endoscopy System brochure. In addition, the Company will initiate a direct mail campaign to focus on attendees from industry related meetings, conventions and trade shows.
The AAI team includes marketing, creative and technical specialists as well as consultants drawn from the medical, engineering and dental professions; people with experience in business development who have helped clients build partnerships to leverage their marketing and promotional budgets. They offer complete media research, planning, placement and ad tracking analysis. They have been highly regarded in the marketing field for forty-five years and have assisted numerous medical companies achieve their marketing goals.
"We are pleased to be working with AAI to assist Solos in gaining broader exposure to the breast endoscopy market. We are currently reaching approximately 25 percent of the market and hope to double that amount with our 2010 campaign. I was impressed with the previous results that we achieved and have high expectations for what our present marketing campaign will accomplish," stated Bob Segersten, President of Solos Endoscopy, Inc.
For more information on Advertising Associates International, visit: www.aai-agency.com
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.
You May Also Like